Core Hint: The Photonics Industry & Technology Development Association (PIDA) pointed out that the global medical imaging market was US$ 98.4 billion in 2013 and is expected to reach US$ 114 billion in 2016, with a compound annual growth rate of 4%. According to PIDA, the global leading medical imaging manufacturers are Siemens, Philips, GE, Johnson & Johnson. Although the revenue of the 4 leading medical imaging manufacturers in the past 3 years has remained flat or slightly declined, the high-margin and high-value-added medical market still attracts manufacturers from other fields to invest, and the overall annual compound growth rate maintains at 4%.

　　PIDA pointed out that the global medical imaging market was US$ 98.4 billion in 2013 and is expected to reach US$ 114 billion in 2016, with a compound annual growth rate of 4%.

　　According to PIDA, the main global leading manufacturers of medical imaging are Siemens, Philips, GE, and Johnson & Johnson. Although the revenue of the 3 leading medical imaging manufacturers in the past 4 years has remained flat or slightly declined, the high-margin and high-value-added medical market still attracts manufacturers from other fields to invest, and the overall annual compound growth rate maintains at 4%.

　　Regarding Taiwan's medical imaging industry, according to statistics from the Council for Economic Planning and Development Committee, Executive Yuan, Taiwan's elderly population accounted for 11% in 2010 and is expected to reach 39% in 2060, ranking second in the world, second only to Qatar's 41%.

　　In the face of ageing population, Taiwan has proposed many relevant policies, including the implementation of medical and health insurance projects, and the promotion of biomedical research and development centers; it will drive business opportunities in the medical industry and increase the demand for medical devices.

　　According to PIDA, the biomedical optoelectronic industry can be roughly divided into three major fields: biomedical sensing, medical imaging, and optical therapy; among them, through the presentation of medical images, the non-invasive way to see through the human body to diagnose tissue lesions is the most direct and effective method.

　　In the face of fierce competition, PIDA believes that the strategies adopted by major international manufacturers present two major directions. The first is through merging and cooperation to shorten product development cycle and security certification time to reduce the cost.

　　The second is more investment in research and development of current technology, which can also be a feasible solution to strengthen its competitive edge.